n,n-dimethylarginine has been researched along with EBV Infections in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barth, S; Cassel, C; Deng, W; Fischer, U; Grässer, FA; Gross, H; Hennard, C; Kremmer, E; Leonhardt, H; Mamiani, A; Masouris, I; Moritz, B; Neuenkirchen, N; Noessner, E; Ostareck, D; Ostareck-Lederer, A; Stober-Grässer, U | 1 |
1 other study(ies) available for n,n-dimethylarginine and EBV Infections
Article | Year |
---|---|
Binding of the heterogeneous ribonucleoprotein K (hnRNP K) to the Epstein-Barr virus nuclear antigen 2 (EBNA2) enhances viral LMP2A expression.
Topics: Antibodies, Monoclonal; Antibody Specificity; Arginine; Cell Line; DNA; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Heterogeneous-Nuclear Ribonucleoprotein K; Humans; Immunoprecipitation; Methylation; Molecular Sequence Data; Multiprotein Complexes; Mutant Proteins; Promoter Regions, Genetic; Protein Binding; Protein Transport; Repetitive Sequences, Amino Acid; snRNP Core Proteins; Transfection; Viral Matrix Proteins; Viral Proteins | 2012 |